> top > docs > PMC:3317373 > spans > 18096-19483 > annotations

PMC:3317373 / 18096-19483 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
22529521-15856023-67992103 352-354 15856023 denotes 21
22529521-15139523-67992104 494-496 15139523 denotes 22
22529521-18715849-67992105 671-672 18715849 denotes 4
22529521-19125683-67992106 674-675 19125683 denotes 5
22529521-19394962-67992107 677-679 19394962 denotes 23
22529521-16585964-67992108 947-949 16585964 denotes 24
22529521-18241676-67992109 1202-1204 18241676 denotes 25
22529521-20486765-67992110 1383-1385 20486765 denotes 26

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T8049 1372-1373 -RRB- denotes )
T8048 1367-1372 NN denotes MAPKs
T8047 1366-1367 -LRB- denotes (
T8046 1359-1365 NN denotes kinase
T8045 1351-1358 NN denotes protein
T8044 1333-1350 JJ denotes mitogen-activated
T8043 1324-1332 JJ denotes upstream
T8042 1320-1323 DT denotes the
T8041 1317-1319 IN denotes by
T8040 1307-1316 VB denotes regulated
T8039 1304-1306 VB denotes be
T8038 1300-1303 MD denotes may
T8037 1294-1299 WDT denotes which
T8036 1292-1293 -COMMA- denotes ,
T8035 1288-1292 NN denotes Nrf2
T8034 1284-1287 CC denotes and
T8033 1278-1283 NN denotes NF-κB
T8032 1270-1277 IN denotes between
T8031 1260-1269 NN denotes crosstalk
T8030 1249-1259 NN denotes complicate
T8029 1239-1248 JJ denotes potential
T8028 1235-1238 DT denotes the
T8027 1226-1234 VB denotes indicate
T8026 1217-1225 NN denotes findings
T8025 1211-1216 DT denotes these
T8024 1207-1210 PDT denotes All
T8023 1204-1205 -RRB- denotes ]
T8022 1202-1204 CD denotes 25
T8021 1201-1202 -LRB- denotes [
T8020 1185-1200 NN denotes hypoacetylation
T8019 1177-1184 NN denotes histone
T8018 1171-1176 JJ denotes local
T8017 1168-1170 CC denotes or
T8016 1164-1167 NN denotes CBP
T8015 1161-1163 IN denotes of
T8014 1154-1160 NN denotes domain
T8013 1146-1153 NN denotes CH1-KIX
T8012 1142-1145 DT denotes the
T8011 1137-1141 IN denotes with
T8010 1125-1136 NN denotes interaction
T8009 1113-1124 JJ denotes competitive
T8008 1110-1112 IN denotes by
T8007 1104-1109 NN denotes level
T8006 1088-1103 JJ denotes transcriptional
T8005 1085-1087 IN denotes at
T8004 1077-1084 NN denotes pathway
T8003 1068-1076 NN denotes Nrf2-ARE
T8002 1064-1067 DT denotes the
T8001 1054-1063 VB denotes repressed
T8000 1046-1053 NN denotes subunit
T7999 1042-1045 NN denotes p65
T7998 1036-1041 NN denotes NF-κB
T7997 1029-1034 NN denotes level
T7996 1013-1028 JJ denotes transcriptional
T7995 1010-1012 IN denotes at
T7994 1005-1009 NN denotes Nrf2
T7993 997-1004 VB denotes inhibit
T7992 993-996 MD denotes can
T7991 987-992 NN denotes NF-κB
T7990 982-986 IN denotes that
T7989 973-981 VB denotes reported
T7988 970-972 VB denotes is
T7987 967-969 PRP denotes it
T7986 965-966 -COMMA- denotes ,
T7985 952-965 RB denotes Interestingly
T7984 949-950 -RRB- denotes ]
T7983 947-949 CD denotes 24
T7982 946-947 -LRB- denotes [
T7981 939-945 NN denotes sepsis
T7980 926-938 JJ denotes experimental
T7979 920-925 IN denotes after
T7978 915-919 NN denotes mice
T7977 900-914 JJ denotes Nrf2-deficient
T7976 897-899 IN denotes of
T7975 885-896 NN denotes fibroblasts
T7974 875-884 JJ denotes embryonic
T7973 869-874 NN denotes mouse
T7972 865-868 CC denotes and
T7971 863-864 -COMMA- denotes ,
T7970 852-863 NN denotes macrophages
T7969 850-851 -COMMA- denotes ,
T7968 846-850 NN denotes lung
T7967 843-845 IN denotes in
T7966 832-842 VB denotes discovered
T7965 827-831 RB denotes also
T7964 824-826 VB denotes is
T7963 818-823 NN denotes NF-κB
T7962 815-817 IN denotes of
T7961 804-814 NN denotes activation
T7960 795-803 VB denotes Enhanced
T7959 787-793 NN denotes injury
T7958 779-786 NN denotes scratch
T7957 773-778 IN denotes after
T7956 762-772 NN denotes astrocytes
T7955 753-761 VB denotes cultured
T7954 750-752 IN denotes in
T7953 742-749 VB denotes existed
T7952 729-741 NN denotes relationship
T7951 724-728 JJ denotes such
T7950 714-723 VB denotes confirmed
T7949 706-713 RB denotes further
T7948 700-705 NN denotes study
T7947 695-699 DT denotes this
T7946 690-694 IN denotes from
T7945 682-689 NN denotes Results
T7944 679-680 -RRB- denotes ]
T7943 677-679 CD denotes 23
T7942 675-676 -COMMA- denotes ,
T7941 674-675 CD denotes 5
T7940 672-673 -COMMA- denotes ,
T7939 671-672 CD denotes 4
T7938 670-671 -LRB- denotes [
T7937 666-669 NNP denotes TBI
T7936 660-665 IN denotes after
T7935 650-659 NN denotes intestine
T7934 646-649 CC denotes and
T7933 644-645 -COMMA- denotes ,
T7932 639-644 NN denotes brain
T7931 637-638 -COMMA- denotes ,
T7930 633-637 NN denotes lung
T7929 630-632 IN denotes in
T7928 621-629 NN denotes response
T7927 608-620 JJ denotes inflammatory
T7926 604-607 CC denotes and
T7925 595-603 NN denotes activity
T7924 589-594 NN denotes NF-κB
T7923 586-588 IN denotes of
T7922 573-585 NN denotes augmentation
T7921 565-572 VB denotes induces
T7920 560-564 NN denotes Nrf2
T7919 557-559 IN denotes of
T7918 547-556 NN denotes depletion
T7917 542-546 IN denotes that
T7916 533-541 VB denotes indicate
T7915 525-532 NN denotes studies
T7914 516-524 JJ denotes previous
T7913 512-515 PRP-DOLLAR- denotes our
T7912 510-511 -COMMA- denotes ,
T7911 499-510 RB denotes Furthermore
T7910 496-497 -RRB- denotes ]
T7909 494-496 CD denotes 22
T7908 493-494 -LRB- denotes [
T7907 491-492 -RRB- denotes )
T7906 488-491 NN denotes CUR
T7905 487-488 -LRB- denotes (
T7904 478-486 NN denotes curcumin
T7903 474-477 CC denotes and
T7902 470-473 NN denotes SFN
T7901 467-469 IN denotes as
T7900 462-466 JJ denotes such
T7899 460-461 -COMMA- denotes ,
T7898 450-460 NN denotes activators
T7897 445-449 NN denotes Nrf2
T7896 437-444 JJ denotes diverse
T7895 434-436 IN denotes by
T7894 423-433 VB denotes attenuated
T7893 420-422 VB denotes be
T7892 414-419 MD denotes could
T7891 412-413 -RRB- denotes )
T7890 409-412 NN denotes LPS
T7889 408-409 -LRB- denotes (
T7888 389-407 NN denotes lipopolysaccharide
T7887 386-388 IN denotes by
T7886 378-385 VB denotes induced
T7885 367-377 NN denotes activation
T7884 361-366 NN denotes NF-κB
T7883 357-360 CC denotes And
T7882 354-355 -RRB- denotes ]
T7881 352-354 CD denotes 21
T7880 351-352 -LRB- denotes [
T7879 341-350 NN denotes signaling
T7878 335-340 NN denotes NF-κB
T7877 323-334 VB denotes alleviating
T7876 310-322 RB denotes consequently
T7875 308-309 -COMMA- denotes ,
T7874 295-308 NN denotes translocation
T7873 287-294 JJ denotes nuclear
T7872 279-286 NN denotes subunit
T7871 273-278 NN denotes NF-κB
T7870 269-272 NN denotes p65
T7869 265-268 CC denotes and
T7868 249-264 NN denotes phosphorylation
T7867 241-248 NN denotes IKK/IκB
T7866 233-240 VB denotes inhibit
T7865 230-232 TO denotes to
T7864 225-229 JJ denotes able
T7863 222-224 VB denotes be
T7862 219-221 TO denotes to
T7861 213-218 VB denotes found
T7860 210-212 VB denotes is
T7859 206-209 NN denotes SFN
T7858 203-205 IN denotes of
T7857 188-202 NN denotes Administration
T7856 177-186 NN denotes signaling
T7855 171-176 NN denotes NF-κB
T7854 168-170 IN denotes by
T7853 159-167 VB denotes mediated
T7852 155-158 VB denotes are
T7851 149-154 WDT denotes which
T7850 140-148 NN denotes pathways
T7849 124-139 JJ denotes proinflammatory
T7848 121-123 IN denotes of
T7847 109-120 NN denotes suppression
T7846 106-108 IN denotes by
T7845 97-105 VB denotes achieved
T7844 94-96 VB denotes be
T7843 90-93 MD denotes may
T7842 85-89 NN denotes Nrf2
T7841 82-84 IN denotes of
T7840 75-81 NN denotes effect
T7839 63-74 JJ denotes antioxidant
T7838 58-62 IN denotes that
T7837 46-57 NN denotes possibility
T7836 42-45 DT denotes the
T7835 34-41 VB denotes suggest
T7834 26-33 NN denotes studies
T8053 1385-1386 -RRB- denotes ]
T8052 1383-1385 CD denotes 26
T8051 1382-1383 -LRB- denotes [
T8050 1374-1381 NN denotes pathway
T7833 19-25 JJ denotes animal
T7832 14-18 IN denotes from
T7831 5-13 VB denotes obtained
T7830 0-4 NN denotes Data
R6373 T7830 T7831 arg2Of Data,obtained
R6374 T7830 T7835 arg1Of Data,suggest
R6375 T7831 T7832 arg1Of obtained,from
R6376 T7834 T7832 arg2Of studies,from
R6377 T7834 T7833 arg1Of studies,animal
R6378 T7837 T7835 arg2Of possibility,suggest
R6379 T7837 T7836 arg1Of possibility,the
R6380 T7840 T7839 arg1Of effect,antioxidant
R6381 T7840 T7841 arg1Of effect,of
R6382 T7840 T7843 arg1Of effect,may
R6383 T7840 T7844 arg1Of effect,be
R6384 T7840 T7845 arg2Of effect,achieved
R6385 T7842 T7841 arg2Of Nrf2,of
R6386 T7845 T7837 arg2Of achieved,possibility
R6387 T7845 T7838 arg1Of achieved,that
R6388 T7845 T7843 arg2Of achieved,may
R6389 T7845 T7844 arg2Of achieved,be
R6390 T7847 T7845 arg1Of suppression,achieved
R6391 T7847 T7846 arg2Of suppression,by
R6392 T7847 T7848 arg1Of suppression,of
R6393 T7850 T7848 arg2Of pathways,of
R6394 T7850 T7849 arg1Of pathways,proinflammatory
R6395 T7850 T7851 arg1Of pathways,which
R6396 T7850 T7852 arg1Of pathways,are
R6397 T7850 T7853 arg2Of pathways,mediated
R6398 T7853 T7852 arg2Of mediated,are
R6399 T7856 T7853 arg1Of signaling,mediated
R6400 T7856 T7854 arg2Of signaling,by
R6401 T7856 T7855 arg1Of signaling,NF-κB
R6402 T7857 T7858 arg1Of Administration,of
R6403 T7857 T7860 arg1Of Administration,is
R6404 T7857 T7861 arg2Of Administration,found
R6405 T7857 T7863 arg1Of Administration,be
R6406 T7857 T7864 arg1Of Administration,able
R6407 T7857 T7866 arg1Of Administration,inhibit
R6408 T7857 T7877 arg1Of Administration,alleviating
R6409 T7859 T7858 arg2Of SFN,of
R6410 T7861 T7860 arg2Of found,is
R6411 T7863 T7861 arg3Of be,found
R6412 T7863 T7862 arg1Of be,to
R6413 T7864 T7863 arg2Of able,be
R6414 T7866 T7864 arg2Of inhibit,able
R6415 T7866 T7865 arg1Of inhibit,to
R6416 T7866 T7875 arg1Of inhibit,","
R6417 T7866 T7877 modOf inhibit,alleviating
R6418 T7868 T7867 arg1Of phosphorylation,IKK/IκB
R6419 T7868 T7869 arg1Of phosphorylation,and
R6420 T7869 T7866 arg2Of and,inhibit
R6421 T7874 T7869 arg2Of translocation,and
R6422 T7874 T7870 arg1Of translocation,p65
R6423 T7874 T7871 arg1Of translocation,NF-κB
R6424 T7874 T7872 arg1Of translocation,subunit
R6425 T7874 T7873 arg1Of translocation,nuclear
R6426 T7877 T7876 arg1Of alleviating,consequently
R6427 T7879 T7877 arg2Of signaling,alleviating
R6428 T7879 T7878 arg1Of signaling,NF-κB
R6429 T7879 T7880 arg1Of signaling,[
R6430 T7881 T7880 arg2Of 21,[
R6431 T7882 T7880 arg3Of ],[
R6432 T7885 T7884 arg1Of activation,NF-κB
R6433 T7885 T7886 arg2Of activation,induced
R6434 T7885 T7892 arg1Of activation,could
R6435 T7885 T7893 arg1Of activation,be
R6436 T7885 T7894 arg2Of activation,attenuated
R6437 T7888 T7886 arg1Of lipopolysaccharide,induced
R6438 T7888 T7887 arg2Of lipopolysaccharide,by
R6439 T7888 T7889 arg1Of lipopolysaccharide,(
R6440 T7890 T7889 arg2Of LPS,(
R6441 T7891 T7889 arg3Of ),(
R6442 T7894 T7883 arg1Of attenuated,And
R6443 T7894 T7892 arg2Of attenuated,could
R6444 T7894 T7893 arg2Of attenuated,be
R6445 T7894 T7908 arg1Of attenuated,[
R6446 T7898 T7894 arg1Of activators,attenuated
R6447 T7898 T7895 arg2Of activators,by
R6448 T7898 T7896 arg1Of activators,diverse
R6449 T7898 T7897 arg1Of activators,Nrf2
R6450 T7898 T7899 arg1Of activators,","
R6451 T7898 T7901 arg1Of activators,as
R6452 T7901 T7900 arg1Of as,such
R6453 T7902 T7903 arg1Of SFN,and
R6454 T7903 T7901 arg2Of and,as
R6455 T7903 T7905 arg1Of and,(
R6456 T7904 T7903 arg2Of curcumin,and
R6457 T7906 T7905 arg2Of CUR,(
R6458 T7907 T7905 arg3Of ),(
R6459 T7909 T7908 arg2Of 22,[
R6460 T7910 T7908 arg3Of ],[
R6461 T7915 T7913 arg1Of studies,our
R6462 T7915 T7914 arg1Of studies,previous
R6463 T7915 T7916 arg1Of studies,indicate
R6464 T7916 T7911 arg1Of indicate,Furthermore
R6465 T7916 T7912 arg1Of indicate,","
R6466 T7918 T7919 arg1Of depletion,of
R6467 T7918 T7921 arg1Of depletion,induces
R6468 T7920 T7919 arg2Of Nrf2,of
R6469 T7921 T7916 arg2Of induces,indicate
R6470 T7921 T7917 arg1Of induces,that
R6471 T7922 T7921 arg2Of augmentation,induces
R6472 T7922 T7923 arg1Of augmentation,of
R6473 T7922 T7929 arg1Of augmentation,in
R6474 T7922 T7936 arg1Of augmentation,after
R6475 T7925 T7924 arg1Of activity,NF-κB
R6476 T7925 T7926 arg1Of activity,and
R6477 T7926 T7923 arg2Of and,of
R6478 T7928 T7926 arg2Of response,and
R6479 T7928 T7927 arg1Of response,inflammatory
R6480 T7930 T7931 arg1Of lung,","
R6481 T7931 T7934 arg1Of ",",and
R6482 T7932 T7931 arg2Of brain,","
R6483 T7934 T7929 arg2Of and,in
R6484 T7934 T7933 arg1Of and,","
R6485 T7935 T7934 arg2Of intestine,and
R6486 T7937 T7936 arg2Of TBI,after
R6487 T7937 T7938 arg1Of TBI,[
R6488 T7939 T7940 arg1Of 4,","
R6489 T7940 T7938 arg2Of ",",[
R6490 T7940 T7942 arg1Of ",",","
R6491 T7941 T7940 arg2Of 5,","
R6492 T7943 T7942 arg2Of 23,","
R6493 T7944 T7938 arg3Of ],[
R6494 T7945 T7946 arg1Of Results,from
R6495 T7945 T7950 arg1Of Results,confirmed
R6496 T7948 T7946 arg2Of study,from
R6497 T7948 T7947 arg1Of study,this
R6498 T7950 T7949 arg1Of confirmed,further
R6499 T7952 T7951 arg1Of relationship,such
R6500 T7952 T7953 arg1Of relationship,existed
R6501 T7953 T7950 arg2Of existed,confirmed
R6502 T7953 T7954 arg1Of existed,in
R6503 T7953 T7957 arg1Of existed,after
R6504 T7956 T7954 arg2Of astrocytes,in
R6505 T7956 T7955 arg2Of astrocytes,cultured
R6506 T7959 T7957 arg2Of injury,after
R6507 T7959 T7958 arg1Of injury,scratch
R6508 T7961 T7960 arg2Of activation,Enhanced
R6509 T7961 T7962 arg1Of activation,of
R6510 T7961 T7964 arg1Of activation,is
R6511 T7961 T7966 arg2Of activation,discovered
R6512 T7963 T7962 arg2Of NF-κB,of
R6513 T7966 T7964 arg2Of discovered,is
R6514 T7966 T7965 arg1Of discovered,also
R6515 T7966 T7967 arg1Of discovered,in
R6516 T7966 T7979 arg1Of discovered,after
R6517 T7966 T7982 arg1Of discovered,[
R6518 T7968 T7969 arg1Of lung,","
R6519 T7969 T7972 arg1Of ",",and
R6520 T7970 T7969 arg2Of macrophages,","
R6521 T7972 T7967 arg2Of and,in
R6522 T7972 T7971 arg1Of and,","
R6523 T7975 T7972 arg2Of fibroblasts,and
R6524 T7975 T7973 arg1Of fibroblasts,mouse
R6525 T7975 T7974 arg1Of fibroblasts,embryonic
R6526 T7975 T7976 arg1Of fibroblasts,of
R6527 T7978 T7976 arg2Of mice,of
R6528 T7978 T7977 arg1Of mice,Nrf2-deficient
R6529 T7981 T7979 arg2Of sepsis,after
R6530 T7981 T7980 arg1Of sepsis,experimental
R6531 T7983 T7982 arg2Of 24,[
R6532 T7984 T7982 arg3Of ],[
R6533 T7987 T7988 arg1Of it,is
R6534 T7987 T7989 arg2Of it,reported
R6535 T7989 T7985 arg1Of reported,Interestingly
R6536 T7989 T7986 arg1Of reported,","
R6537 T7989 T7988 arg2Of reported,is
R6538 T7991 T7992 arg1Of NF-κB,can
R6539 T7991 T7993 arg1Of NF-κB,inhibit
R6540 T7993 T7989 arg3Of inhibit,reported
R6541 T7993 T7990 arg1Of inhibit,that
R6542 T7993 T7992 arg2Of inhibit,can
R6543 T7993 T7995 arg1Of inhibit,at
R6544 T7994 T7993 arg2Of Nrf2,inhibit
R6545 T7997 T7995 arg2Of level,at
R6546 T7997 T7996 arg1Of level,transcriptional
R6547 T8000 T7998 arg1Of subunit,NF-κB
R6548 T8000 T7999 arg1Of subunit,p65
R6549 T8000 T8001 arg1Of subunit,repressed
R6550 T8001 T8008 arg1Of repressed,by
R6551 T8004 T8001 arg2Of pathway,repressed
R6552 T8004 T8002 arg1Of pathway,the
R6553 T8004 T8003 arg1Of pathway,Nrf2-ARE
R6554 T8004 T8005 arg1Of pathway,at
R6555 T8007 T8005 arg2Of level,at
R6556 T8007 T8006 arg1Of level,transcriptional
R6557 T8010 T8009 arg1Of interaction,competitive
R6558 T8010 T8011 arg1Of interaction,with
R6559 T8010 T8017 arg1Of interaction,or
R6560 T8014 T8011 arg2Of domain,with
R6561 T8014 T8012 arg1Of domain,the
R6562 T8014 T8013 arg1Of domain,CH1-KIX
R6563 T8014 T8015 arg1Of domain,of
R6564 T8016 T8015 arg2Of CBP,of
R6565 T8017 T8008 arg2Of or,by
R6566 T8020 T8017 arg2Of hypoacetylation,or
R6567 T8020 T8018 arg1Of hypoacetylation,local
R6568 T8020 T8019 arg1Of hypoacetylation,histone
R6569 T8020 T8021 arg1Of hypoacetylation,[
R6570 T8022 T8021 arg2Of 25,[
R6571 T8023 T8021 arg3Of ],[
R6572 T8026 T8024 arg1Of findings,All
R6573 T8026 T8025 arg1Of findings,these
R6574 T8026 T8027 arg1Of findings,indicate
R6575 T8031 T8027 arg2Of crosstalk,indicate
R6576 T8031 T8028 arg1Of crosstalk,the
R6577 T8031 T8029 arg1Of crosstalk,potential
R6578 T8031 T8030 arg1Of crosstalk,complicate
R6579 T8031 T8032 arg1Of crosstalk,between
R6580 T8033 T8034 arg1Of NF-κB,and
R6581 T8034 T8032 arg2Of and,between
R6582 T8034 T8036 arg1Of and,","
R6583 T8034 T8037 arg1Of and,which
R6584 T8034 T8038 arg1Of and,may
R6585 T8034 T8039 arg1Of and,be
R6586 T8034 T8040 arg2Of and,regulated
R6587 T8035 T8034 arg2Of Nrf2,and
R6588 T8040 T8038 arg2Of regulated,may
R6589 T8040 T8039 arg2Of regulated,be
R6590 T8040 T8051 arg1Of regulated,[
R6591 T8046 T8044 arg1Of kinase,mitogen-activated
R6592 T8046 T8045 arg1Of kinase,protein
R6593 T8046 T8047 arg1Of kinase,(
R6594 T8048 T8047 arg2Of MAPKs,(
R6595 T8049 T8047 arg3Of ),(
R6596 T8050 T8040 arg1Of pathway,regulated
R6597 T8050 T8041 arg2Of pathway,by
R6598 T8050 T8042 arg1Of pathway,the
R6599 T8050 T8043 arg1Of pathway,upstream
R6600 T8050 T8046 arg1Of pathway,kinase
R6601 T8052 T8051 arg2Of 26,[
R6602 T8053 T8051 arg3Of ],[

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T7332 1042-1045 Protein denotes p65
T7331 269-272 Protein denotes p65

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T8392 1164-1167 http://www.uniprot.org/uniprot/Q92793 denotes CBP
T8391 1042-1045 http://www.uniprot.org/uniprot/P21579 denotes p65
T8390 269-272 http://www.uniprot.org/uniprot/P21579 denotes p65
T8389 1042-1045 http://www.uniprot.org/uniprot/Q04206 denotes p65
T8388 269-272 http://www.uniprot.org/uniprot/Q04206 denotes p65

UBERON-AE

Id Subject Object Predicate Lexical cue
T7210 650-659 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestine
T7209 846-850 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T7208 633-637 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T7200 639-644 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain

GO-BP

Id Subject Object Predicate Lexical cue
T7365 1341-1365 http://purl.obolibrary.org/obo/GO_0032111 denotes activated protein kinase
T7364 1341-1365 http://purl.obolibrary.org/obo/GO_0030295 denotes activated protein kinase
T7363 1341-1365 http://purl.obolibrary.org/obo/GO_0032147 denotes activated protein kinase
T7362 1341-1365 http://purl.obolibrary.org/obo/GO_0034199 denotes activated protein kinase
T7361 249-264 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T7360 241-244 http://purl.obolibrary.org/obo/GO_0008384 denotes IKK
T7359 341-350 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T7358 177-186 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T7357 335-350 http://purl.obolibrary.org/obo/GO_0038061 denotes NF-κB signaling
T7356 171-186 http://purl.obolibrary.org/obo/GO_0038061 denotes NF-κB signaling
T7350 608-629 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T7344 804-823 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB

GO-MF

Id Subject Object Predicate Lexical cue
T8295 1341-1365 http://purl.obolibrary.org/obo/GO_0030295 denotes activated protein kinase
T8294 1164-1167 http://purl.obolibrary.org/obo/GO_0008140 denotes CBP
T8293 241-244 http://purl.obolibrary.org/obo/GO_0008384 denotes IKK

sentences

Id Subject Object Predicate Lexical cue
T7238 1207-1387 Sentence denotes All these findings indicate the potential complicate crosstalk between NF-κB and Nrf2, which may be regulated by the upstream mitogen-activated protein kinase (MAPKs) pathway [26].
T7237 1036-1206 Sentence denotes NF-κB p65 subunit repressed the Nrf2-ARE pathway at transcriptional level by competitive interaction with the CH1-KIX domain of CBP or local histone hypoacetylation [25].
T7236 952-1035 Sentence denotes Interestingly, it is reported that NF-κB can inhibit Nrf2 at transcriptional level.
T7235 795-951 Sentence denotes Enhanced activation of NF-κB is also discovered in lung, macrophages, and mouse embryonic fibroblasts of Nrf2-deficient mice after experimental sepsis [24].
T7234 682-794 Sentence denotes Results from this study further confirmed such relationship existed in cultured astrocytes after scratch injury.
T7233 499-681 Sentence denotes Furthermore, our previous studies indicate that depletion of Nrf2 induces augmentation of NF-κB activity and inflammatory response in lung, brain, and intestine after TBI [4, 5, 23].
T7232 357-498 Sentence denotes And NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by diverse Nrf2 activators, such as SFN and curcumin (CUR) [22].
T7231 188-356 Sentence denotes Administration of SFN is found to be able to inhibit IKK/IκB phosphorylation and p65 NF-κB subunit nuclear translocation, consequently alleviating NF-κB signaling [21].
T7230 0-187 Sentence denotes Data obtained from animal studies suggest the possibility that antioxidant effect of Nrf2 may be achieved by suppression of proinflammatory pathways which are mediated by NF-κB signaling.
T176 0-187 Sentence denotes Data obtained from animal studies suggest the possibility that antioxidant effect of Nrf2 may be achieved by suppression of proinflammatory pathways which are mediated by NF-κB signaling.
T177 188-356 Sentence denotes Administration of SFN is found to be able to inhibit IKK/IκB phosphorylation and p65 NF-κB subunit nuclear translocation, consequently alleviating NF-κB signaling [21].
T178 357-498 Sentence denotes And NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by diverse Nrf2 activators, such as SFN and curcumin (CUR) [22].
T179 499-681 Sentence denotes Furthermore, our previous studies indicate that depletion of Nrf2 induces augmentation of NF-κB activity and inflammatory response in lung, brain, and intestine after TBI [4, 5, 23].
T180 682-794 Sentence denotes Results from this study further confirmed such relationship existed in cultured astrocytes after scratch injury.
T181 795-951 Sentence denotes Enhanced activation of NF-κB is also discovered in lung, macrophages, and mouse embryonic fibroblasts of Nrf2-deficient mice after experimental sepsis [24].
T182 952-1035 Sentence denotes Interestingly, it is reported that NF-κB can inhibit Nrf2 at transcriptional level.
T183 1036-1206 Sentence denotes NF-κB p65 subunit repressed the Nrf2-ARE pathway at transcriptional level by competitive interaction with the CH1-KIX domain of CBP or local histone hypoacetylation [25].
T184 1207-1387 Sentence denotes All these findings indicate the potential complicate crosstalk between NF-κB and Nrf2, which may be regulated by the upstream mitogen-activated protein kinase (MAPKs) pathway [26].

ICD10

Id Subject Object Predicate Lexical cue
T8274 787-793 http://purl.bioontology.org/ontology/ICD10/T14.9 denotes injury

simple1

Id Subject Object Predicate Lexical cue
T8347 1042-1045 Protein denotes p65
T8346 269-272 Protein denotes p65

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T9931 1054-1063 Negative_regulation denotes repressed
T9930 233-240 Negative_regulation denotes inhibit
T9929 295-308 Localization denotes translocation
T9906 1042-1045 Protein denotes p65
T9905 269-272 Protein denotes p65
R8149 T9905 T9929 themeOf p65,translocation
R8151 T9906 T9931 themeOf p65,repressed
R8193 T9929 T9930 themeOf translocation,inhibit

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T8487 1125-1136 Binding denotes interaction
T8486 1054-1063 Negative_regulation denotes repressed
T8485 233-240 Negative_regulation denotes inhibit
T8484 295-308 Localization denotes translocation
T8462 1042-1045 Protein denotes p65
T8461 269-272 Protein denotes p65
R6883 T8461 T8484 themeOf p65,translocation
R6884 T8462 T8487 themeOf p65,interaction
R6885 T8462 T8486 themeOf p65,repressed
R6905 T8484 T8485 themeOf translocation,inhibit

DLUT931

Id Subject Object Predicate Lexical cue
T8437 1054-1063 Negative_regulation denotes repressed
T8436 1125-1136 Binding denotes interaction
T8435 233-240 Negative_regulation denotes inhibit
T8434 295-308 Localization denotes translocation
T8411 1042-1045 Protein denotes p65
T8410 269-272 Protein denotes p65
R6832 T8411 T8436 themeOf p65,interaction
R6860 T8434 T8435 themeOf translocation,inhibit
R6861 T8436 T8437 themeOf interaction,repressed
R6831 T8410 T8434 themeOf p65,translocation

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue Speculation
T10086 982-1034 Negative_regulation denotes that NF-κB can inhibit Nrf2 at transcriptional level true
T10085 168-186 Positive_regulation denotes by NF-κB signaling
T10076 335-350 Positive_regulation denotes NF-κB signaling
T10038 361-436 Protein denotes NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by
T10023 915-950 Protein denotes mice after experimental sepsis [24]
T10013 589-594 Protein denotes NF-κB
T10012 409-412 Entity denotes LPS
T10011 1005-1009 Protein denotes Nrf2
T10006 82-89 Protein denotes of Nrf2
T10003 206-209 Protein denotes SFN
T10001 386-413 Entity denotes by lipopolysaccharide (LPS)
T9999 987-992 Protein denotes NF-κB
T9998 450-460 Entity denotes activators
T9994 1367-1372 Protein denotes MAPKs
T9991 1177-1184 Entity denotes histone
T9987 1036-1053 Protein denotes NF-κB p65 subunit
T9985 269-272 Protein denotes p65
T9982 1288-1293 Protein denotes Nrf2,
T9978 1150-1153 Entity denotes KIX
T9977 470-473 Protein denotes SFN
T9975 1164-1167 Protein denotes CBP
T9972 815-823 Protein denotes of NF-κB
T9969 1317-1386 Protein denotes by the upstream mitogen-activated protein kinase (MAPKs) pathway [26]
T9966 753-772 Entity denotes cultured astrocytes
T9963 1278-1283 Protein denotes NF-κB
T9958 335-340 Protein denotes NF-κB
T9956 171-176 Protein denotes NF-κB
T9954 852-863 Entity denotes macrophages
T9949 1137-1160 Entity denotes with the CH1-KIX domain
T9945 269-308 Protein denotes p65 NF-κB subunit nuclear translocation
T9944 1036-1041 Protein denotes NF-κB
T10059 795-896 Positive_regulation denotes Enhanced activation of NF-κB is also discovered in lung, macrophages, and mouse embryonic fibroblasts
T10057 361-436 Negative_regulation denotes NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by true
T10056 795-823 Positive_regulation denotes Enhanced activation of NF-κB
T10051 478-492 Entity denotes curcumin (CUR)
T10048 869-896 Entity denotes mouse embryonic fibroblasts
T10041 63-74 Entity denotes antioxidant
R8184 T9956 T10085 causeOf NF-κB,by NF-κB signaling
R8189 T9958 T10076 causeOf NF-κB,NF-κB signaling
R8200 T9972 T10059 themeOf of NF-κB,"Enhanced activation of NF-κB is also discovered in lung, macrophages, and mouse embryonic fibroblasts"
R8216 T9999 T10086 causeOf NF-κB,that NF-κB can inhibit Nrf2 at transcriptional level
R8227 T10011 T10086 themeOf Nrf2,that NF-κB can inhibit Nrf2 at transcriptional level
R8232 T10038 T10057 causeOf NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by,NF-κB activation induced by lipopolysaccharide (LPS) could be attenuated by
R8233 T10059 T10056 themeOf "Enhanced activation of NF-κB is also discovered in lung, macrophages, and mouse embryonic fibroblasts",Enhanced activation of NF-κB

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T9439 1304-1306 VB denotes be
T9438 1300-1303 MD denotes may
T9437 1294-1299 WDT denotes which
T9436 1292-1293 , denotes ,
T9435 1288-1292 NNP denotes Nrf2
T9434 1284-1287 CC denotes and
T9433 1278-1283 NNP denotes NF-κB
T9432 1270-1277 IN denotes between
T9431 1260-1269 NN denotes crosstalk
T9430 1249-1259 VBP denotes complicate
T9429 1239-1248 JJ denotes potential
T9428 1235-1238 DT denotes the
T9427 1226-1234 VBP denotes indicate
T9426 1217-1225 NNS denotes findings
T9425 1211-1216 DT denotes these
T9424 1207-1210 PDT denotes All
T9423 1205-1206 . denotes .
T9422 1204-1205 NNP denotes ]
T9421 1202-1204 CD denotes 25
T9420 1201-1202 NNP denotes [
T9419 1185-1200 NN denotes hypoacetylation
T9418 1177-1184 NN denotes histone
T9417 1171-1176 JJ denotes local
T9416 1168-1170 CC denotes or
T9415 1164-1167 NNP denotes CBP
T9414 1161-1163 IN denotes of
T9413 1154-1160 NN denotes domain
T9412 1146-1153 NNP denotes CH1-KIX
T9410 1137-1141 IN denotes with
T9409 1125-1136 NN denotes interaction
T9408 1113-1124 JJ denotes competitive
T9407 1110-1112 IN denotes by
T9406 1104-1109 NN denotes level
T9405 1088-1103 JJ denotes transcriptional
T9404 1085-1087 IN denotes at
T9403 1077-1084 NN denotes pathway
T9402 1068-1076 JJ denotes Nrf2-ARE
T9401 1064-1067 DT denotes the
T9400 1054-1063 VBD denotes repressed
T9399 1046-1053 NN denotes subunit
T9398 1042-1045 CD denotes p65
T9397 1036-1041 NNP denotes NF-κB
T9396 1034-1035 . denotes .
T9395 1029-1034 NN denotes level
T9394 1013-1028 JJ denotes transcriptional
T9393 1010-1012 IN denotes at
T9392 1005-1009 NNP denotes Nrf2
T9391 997-1004 VB denotes inhibit
T9390 993-996 MD denotes can
T9389 987-992 NNP denotes NF-κB
T9388 982-986 IN denotes that
T9387 973-981 VBN denotes reported
T9386 970-972 VBZ denotes is
T9385 967-969 PRP denotes it
T9384 965-966 , denotes ,
T9383 952-965 RB denotes Interestingly
T9382 950-951 . denotes .
T9381 949-950 NNP denotes ]
T9380 947-949 CD denotes 24
T9379 946-947 NNP denotes [
T9378 939-945 NN denotes sepsis
T9377 926-938 JJ denotes experimental
T9376 920-925 IN denotes after
T9375 915-919 NNS denotes mice
T9374 900-914 JJ denotes Nrf2-deficient
T9373 897-899 IN denotes of
T9372 885-896 NNS denotes fibroblasts
T9371 875-884 JJ denotes embryonic
T9370 869-874 NN denotes mouse
T9369 865-868 CC denotes and
T9368 863-864 , denotes ,
T9367 852-863 NNS denotes macrophages
T9366 850-851 , denotes ,
T9365 846-850 NN denotes lung
T9364 843-845 IN denotes in
T9363 832-842 VBN denotes discovered
T9362 827-831 RB denotes also
T9361 824-826 VBZ denotes is
T9360 818-823 NNP denotes NF-κB
T9359 815-817 IN denotes of
T9358 804-814 NN denotes activation
T9357 795-803 VBN denotes Enhanced
T9356 793-794 . denotes .
T9355 787-793 NN denotes injury
T9354 779-786 NN denotes scratch
T9353 773-778 IN denotes after
T9352 762-772 NNS denotes astrocytes
T9351 753-761 JJ denotes cultured
T9350 750-752 IN denotes in
T9349 742-749 VBD denotes existed
T9348 729-741 NN denotes relationship
T9347 724-728 JJ denotes such
T9346 714-723 VBD denotes confirmed
T9345 706-713 JJ denotes further
T9344 700-705 NN denotes study
T9343 695-699 DT denotes this
T9342 690-694 IN denotes from
T9341 682-689 NNS denotes Results
T9340 680-681 . denotes .
T9339 679-680 NNP denotes ]
T9338 677-679 CD denotes 23
T9337 675-676 , denotes ,
T9336 674-675 CD denotes 5
T9335 672-673 , denotes ,
T9334 671-672 CD denotes 4
T9333 670-671 NNP denotes [
T9332 666-669 NNP denotes TBI
T9331 660-665 IN denotes after
T9330 650-659 JJ denotes intestine
T9329 646-649 CC denotes and
T9328 644-645 , denotes ,
T9327 639-644 NN denotes brain
T9326 637-638 , denotes ,
T9325 633-637 NN denotes lung
T9324 630-632 IN denotes in
T9323 621-629 NN denotes response
T9322 608-620 JJ denotes inflammatory
T9321 604-607 CC denotes and
T9320 595-603 NN denotes activity
T9319 589-594 JJ denotes NF-κB
T9318 586-588 IN denotes of
T9317 573-585 NN denotes augmentation
T9316 565-572 VBZ denotes induces
T9315 560-564 JJ denotes Nrf2
T9314 557-559 IN denotes of
T9313 547-556 NN denotes depletion
T9312 542-546 IN denotes that
T9311 533-541 VBP denotes indicate
T9310 525-532 NNS denotes studies
T9309 516-524 JJ denotes previous
T9308 512-515 PRP$ denotes our
T9307 510-511 , denotes ,
T9306 499-510 RB denotes Furthermore
T9305 497-498 . denotes .
T9304 496-497 NNP denotes ]
T9303 494-496 CD denotes 22
T9302 493-494 NNP denotes [
T9301 491-492 -RRB- denotes )
T9300 488-491 NNP denotes CUR
T9299 487-488 -LRB- denotes (
T9298 478-486 NN denotes curcumin
T9297 474-477 CC denotes and
T9296 470-473 NNP denotes SFN
T9295 467-469 IN denotes as
T9294 462-466 JJ denotes such
T9293 460-461 , denotes ,
T9292 450-460 NNS denotes activators
T9291 445-449 JJ denotes Nrf2
T9290 437-444 JJ denotes diverse
T9289 434-436 IN denotes by
T9288 423-433 VBN denotes attenuated
T9287 420-422 VB denotes be
T9286 414-419 MD denotes could
T9285 412-413 -RRB- denotes )
T9284 409-412 NNP denotes LPS
T9283 408-409 -LRB- denotes (
T9282 389-407 NN denotes lipopolysaccharide
T9281 386-388 IN denotes by
T9280 378-385 VBN denotes induced
T9279 367-377 NN denotes activation
T9278 361-366 JJ denotes NF-κB
T9277 357-360 CC denotes And
T9276 355-356 . denotes .
T9275 354-355 NNP denotes ]
T9274 352-354 CD denotes 21
T9273 351-352 NNP denotes [
T9272 341-350 VBG denotes signaling
T9271 335-340 JJ denotes NF-κB
T9270 323-334 VBG denotes alleviating
T9269 310-322 RB denotes consequently
T9268 308-309 , denotes ,
T9267 295-308 NN denotes translocation
T9266 287-294 JJ denotes nuclear
T9265 279-286 NN denotes subunit
T9264 273-278 JJ denotes NF-κB
T9263 269-272 CD denotes p65
T9262 265-268 CC denotes and
T9261 249-264 NN denotes phosphorylation
T9260 246-248 NNP denotes κB
T9259 241-246 NNP denotes IKK/I
T9258 233-240 VB denotes inhibit
T9257 230-232 TO denotes to
T9256 225-229 JJ denotes able
T9255 222-224 VB denotes be
T9254 219-221 TO denotes to
T9253 213-218 VBN denotes found
T9252 210-212 VBZ denotes is
T9251 206-209 NNP denotes SFN
T9250 203-205 IN denotes of
T9249 188-202 NNP denotes Administration
T9248 186-187 . denotes .
T9247 177-186 VBG denotes signaling
T9246 171-176 JJ denotes NF-κB
T9245 168-170 IN denotes by
T9244 159-167 VBN denotes mediated
T9243 155-158 VBP denotes are
T9242 149-154 WDT denotes which
T9241 140-148 NNS denotes pathways
T9240 124-139 JJ denotes proinflammatory
T9239 121-123 IN denotes of
T9238 109-120 NN denotes suppression
T9237 106-108 IN denotes by
T9236 97-105 VBN denotes achieved
T9235 94-96 VB denotes be
T9234 90-93 MD denotes may
T9233 85-89 NNP denotes Nrf2
T9232 82-84 IN denotes of
T9231 75-81 NN denotes effect
T9230 63-74 JJ denotes antioxidant
T9229 58-62 WDT denotes that
T9228 46-57 NN denotes possibility
T9227 42-45 DT denotes the
T9226 34-41 VBP denotes suggest
T9225 26-33 NNS denotes studies
T9224 19-25 JJ denotes animal
T9454 1386-1387 . denotes .
T9453 1385-1386 NNP denotes ]
T9452 1383-1385 CD denotes 26
T9451 1382-1383 NNP denotes [
T9450 1374-1381 VBP denotes pathway
T9449 1372-1373 -RRB- denotes )
T9448 1367-1372 NNS denotes MAPKs
T9447 1366-1367 -LRB- denotes (
T9446 1359-1365 NN denotes kinase
T9445 1351-1358 NN denotes protein
T9444 1333-1350 JJ denotes mitogen-activated
T9443 1324-1332 JJ denotes upstream
T9442 1320-1323 DT denotes the
T9441 1317-1319 IN denotes by
T9440 1307-1316 VBN denotes regulated
T9223 14-18 IN denotes from
T9222 5-13 VBD denotes obtained
T9221 0-4 NNP denotes Data
T9411 1142-1145 DT denotes the
R7521 T9253 T9253 ROOT found,found
R7523 T9254 T9255 aux to,be
R7524 T9255 T9253 xcomp be,found
R7525 T9256 T9255 acomp able,be
R7526 T9257 T9258 aux to,inhibit
R7527 T9258 T9256 xcomp inhibit,able
R7529 T9259 T9261 compound IKK/I,phosphorylation
R7530 T9260 T9261 compound κB,phosphorylation
R7531 T9261 T9258 dobj phosphorylation,inhibit
R7533 T9262 T9261 cc and,phosphorylation
R7534 T9263 T9267 nummod p65,translocation
R7536 T9264 T9267 amod NF-κB,translocation
R7537 T9265 T9267 nmod subunit,translocation
R7539 T9266 T9267 amod nuclear,translocation
R7540 T9267 T9261 conj translocation,phosphorylation
R7542 T9268 T9253 punct ",",found
R7543 T9269 T9270 advmod consequently,alleviating
R7544 T9270 T9253 advcl alleviating,found
R7546 T9271 T9270 dobj NF-κB,alleviating
R7547 T9272 T9271 csubj signaling,NF-κB
R7548 T9273 T9275 nmod [,]
R7550 T9274 T9275 nummod 21,]
R7551 T9275 T9272 dobj ],signaling
R7552 T9276 T9253 punct .,found
R7554 T9277 T9288 cc And,attenuated
R7555 T9278 T9279 amod NF-κB,activation
R7556 T9279 T9288 nsubjpass activation,attenuated
R7558 T9280 T9279 acl induced,activation
R7559 T9281 T9280 agent by,induced
R7560 T9282 T9281 pobj lipopolysaccharide,by
R7564 T9283 T9284 punct (,LPS
R7566 T9284 T9282 appos LPS,lipopolysaccharide
R7568 T9285 T9282 punct ),lipopolysaccharide
R7569 T9286 T9288 aux could,attenuated
R7571 T9287 T9288 auxpass be,attenuated
R7572 T9288 T9288 ROOT attenuated,attenuated
R7573 T9289 T9288 agent by,attenuated
R7574 T9290 T9292 amod diverse,activators
R7575 T9291 T9292 amod Nrf2,activators
R7576 T9292 T9289 pobj activators,by
R7578 T9293 T9292 punct ",",activators
R7579 T9294 T9295 amod such,as
R7580 T9295 T9292 prep as,activators
R7581 T9296 T9295 pobj SFN,as
R7583 T9297 T9296 cc and,SFN
R7584 T9298 T9302 nmod curcumin,[
R7586 T9299 T9300 punct (,CUR
R7587 T9300 T9298 appos CUR,curcumin
R7588 T9301 T9302 punct ),[
R7591 T9302 T9296 conj [,SFN
R7593 T9303 T9304 nummod 22,]
R7595 T9304 T9296 conj ],SFN
R7596 T9305 T9288 punct .,attenuated
R7597 T9306 T9311 advmod Furthermore,indicate
R7599 T9307 T9311 punct ",",indicate
R7600 T9308 T9310 poss our,studies
R7601 T9309 T9310 amod previous,studies
R7603 T9310 T9311 nsubj studies,indicate
R7605 T9311 T9311 ROOT indicate,indicate
R7606 T9312 T9316 mark that,induces
R7607 T9313 T9316 nsubj depletion,induces
R7609 T9314 T9313 prep of,depletion
R7610 T9315 T9314 pobj Nrf2,of
R7612 T9316 T9311 ccomp induces,indicate
R7613 T9317 T9316 dobj augmentation,induces
R7614 T9318 T9317 prep of,augmentation
R7616 T9319 T9320 amod NF-κB,activity
R7617 T9320 T9318 pobj activity,of
R7618 T9321 T9320 cc and,activity
R7620 T9322 T9323 amod inflammatory,response
R7621 T9323 T9320 conj response,activity
R7622 T9324 T9323 prep in,response
R7624 T9325 T9324 pobj lung,in
R7625 T9326 T9325 punct ",",lung
R7626 T9327 T9325 conj brain,lung
R7627 T9328 T9327 punct ",",brain
R7628 T9329 T9323 cc and,response
R7629 T9224 T9225 compound animal,studies
R7630 T9330 T9316 oprd intestine,induces
R7631 T9331 T9316 prep after,induces
R7632 T9332 T9333 compound TBI,[
R7633 T9225 T9223 pobj studies,from
R7634 T9333 T9331 pobj [,after
R7635 T9334 T9333 nummod 4,[
R7636 T9335 T9333 punct ",",[
R7637 T9336 T9333 appos 5,[
R7638 T9226 T9222 conj suggest,obtained
R7639 T9337 T9333 punct ",",[
R7640 T9338 T9339 nummod 23,]
R7641 T9227 T9228 det the,possibility
R7642 T9339 T9333 appos ],[
R7643 T9340 T9311 punct .,indicate
R7644 T9341 T9346 nsubj Results,confirmed
R7645 T9228 T9226 dobj possibility,suggest
R7646 T9342 T9341 prep from,Results
R7647 T9343 T9344 det this,study
R7648 T9229 T9236 mark that,achieved
R7649 T9344 T9342 pobj study,from
R7650 T9345 T9346 advmod further,confirmed
R7651 T9346 T9346 ROOT confirmed,confirmed
R7652 T9230 T9231 amod antioxidant,effect
R7653 T9347 T9348 amod such,relationship
R7654 T9348 T9349 nsubj relationship,existed
R7655 T9349 T9346 ccomp existed,confirmed
R7656 T9231 T9236 nsubjpass effect,achieved
R7657 T9232 T9231 prep of,effect
R7658 T9233 T9232 pobj Nrf2,of
R7659 T9234 T9236 aux may,achieved
R7660 T9350 T9349 prep in,existed
R7661 T9235 T9236 auxpass be,achieved
R7662 T9351 T9352 amod cultured,astrocytes
R7663 T9352 T9350 pobj astrocytes,in
R7664 T9236 T9228 acl achieved,possibility
R7665 T9353 T9349 prep after,existed
R7666 T9354 T9355 compound scratch,injury
R7667 T9237 T9236 agent by,achieved
R7668 T9355 T9353 pobj injury,after
R7669 T9356 T9346 punct .,confirmed
R7670 T9357 T9358 amod Enhanced,activation
R7671 T9238 T9237 pobj suppression,by
R7672 T9358 T9363 nsubjpass activation,discovered
R7673 T9359 T9358 prep of,activation
R7674 T9360 T9359 pobj NF-κB,of
R7675 T9361 T9363 auxpass is,discovered
R7676 T9362 T9363 advmod also,discovered
R7677 T9363 T9363 ROOT discovered,discovered
R7678 T9364 T9363 prep in,discovered
R7679 T9239 T9238 prep of,suppression
R7680 T9365 T9364 pobj lung,in
R7681 T9366 T9364 punct ",",in
R7682 T9367 T9364 conj macrophages,in
R7683 T9240 T9241 amod proinflammatory,pathways
R7684 T9368 T9367 punct ",",macrophages
R7685 T9369 T9367 cc and,macrophages
R7686 T9370 T9372 amod mouse,fibroblasts
R7687 T9241 T9239 pobj pathways,of
R7688 T9371 T9372 amod embryonic,fibroblasts
R7689 T9372 T9367 conj fibroblasts,macrophages
R7690 T9242 T9244 nsubjpass which,mediated
R7691 T9373 T9372 prep of,fibroblasts
R7692 T9374 T9375 amod Nrf2-deficient,mice
R7693 T9375 T9373 pobj mice,of
R7694 T9243 T9244 auxpass are,mediated
R7695 T9376 T9363 prep after,discovered
R7696 T9377 T9378 amod experimental,sepsis
R7697 T9244 T9241 relcl mediated,pathways
R7698 T9378 T9376 pobj sepsis,after
R7699 T9379 T9381 nmod [,]
R7700 T9245 T9244 agent by,mediated
R7701 T9380 T9381 nummod 24,]
R7702 T9246 T9247 amod NF-κB,signaling
R7703 T9247 T9245 pcomp signaling,by
R7706 T9248 T9222 punct .,obtained
R7710 T9249 T9253 nsubjpass Administration,found
R7714 T9250 T9249 prep of,Administration
R7716 T9251 T9250 pobj SFN,of
R7717 T9390 T9391 aux can,inhibit
R7718 T9391 T9387 ccomp inhibit,reported
R7719 T9392 T9391 dobj Nrf2,inhibit
R7720 T9252 T9253 auxpass is,found
R7721 T9393 T9391 prep at,inhibit
R7722 T9394 T9395 amod transcriptional,level
R7723 T9411 T9413 det the,domain
R7724 T9395 T9393 pobj level,at
R7725 T9396 T9387 punct .,reported
R7726 T9397 T9399 nmod NF-κB,subunit
R7727 T9398 T9397 nummod p65,NF-κB
R7728 T9399 T9400 nsubj subunit,repressed
R7729 T9400 T9400 ROOT repressed,repressed
R7730 T9401 T9403 det the,pathway
R7731 T9412 T9413 compound CH1-KIX,domain
R7732 T9402 T9403 amod Nrf2-ARE,pathway
R7733 T9403 T9400 dobj pathway,repressed
R7734 T9404 T9400 prep at,repressed
R7735 T9413 T9410 pobj domain,with
R7736 T9405 T9406 amod transcriptional,level
R7737 T9406 T9404 pobj level,at
R7738 T9407 T9400 prep by,repressed
R7739 T9408 T9409 amod competitive,interaction
R7740 T9414 T9413 prep of,domain
R7741 T9409 T9407 pobj interaction,by
R7742 T9410 T9409 prep with,interaction
R7743 T9415 T9414 pobj CBP,of
R7744 T9416 T9415 cc or,CBP
R7745 T9417 T9419 amod local,hypoacetylation
R7746 T9449 T9446 punct ),kinase
R7747 T9418 T9419 compound histone,hypoacetylation
R7748 T9450 T9427 conj pathway,indicate
R7749 T9419 T9420 compound hypoacetylation,[
R7750 T9420 T9415 conj [,CBP
R7753 T9421 T9422 nummod 25,]
R7756 T9422 T9420 appos ],[
R7759 T9423 T9400 punct .,repressed
R7763 T9424 T9426 predet All,findings
R7765 T9425 T9426 det these,findings
R7766 T9426 T9427 nsubj findings,indicate
R7769 T9427 T9427 ROOT indicate,indicate
R7772 T9428 T9431 det the,crosstalk
R7778 T9429 T9431 amod potential,crosstalk
R7782 T9430 T9431 compound complicate,crosstalk
R7786 T9431 T9427 dobj crosstalk,indicate
R7789 T9432 T9431 prep between,crosstalk
R7793 T9433 T9432 pobj NF-κB,between
R7797 T9434 T9433 cc and,NF-κB
R7800 T9435 T9433 conj Nrf2,NF-κB
R7804 T9436 T9433 punct ",",NF-κB
R7807 T9437 T9440 nsubjpass which,regulated
R7811 T9438 T9440 aux may,regulated
R7815 T9439 T9440 auxpass be,regulated
R7819 T9440 T9431 relcl regulated,crosstalk
R7822 T9441 T9440 agent by,regulated
R7829 T9442 T9446 det the,kinase
R7834 T9443 T9446 amod upstream,kinase
R7837 T9444 T9445 amod mitogen-activated,protein
R7840 T9445 T9446 compound protein,kinase
R7844 T9446 T9441 pobj kinase,by
R7847 T9447 T9448 punct (,MAPKs
R7851 T9448 T9446 appos MAPKs,kinase
R7615 T9221 T9222 nsubj Data,obtained
R7619 T9222 T9222 ROOT obtained,obtained
R7623 T9223 T9222 prep from,obtained
R7704 T9381 T9381 ROOT ],]
R7705 T9382 T9363 punct .,discovered
R7707 T9383 T9387 advmod Interestingly,reported
R7708 T9384 T9387 punct ",",reported
R7709 T9385 T9387 nsubjpass it,reported
R7711 T9386 T9387 auxpass is,reported
R7712 T9387 T9387 ROOT reported,reported
R7713 T9388 T9391 mark that,inhibit
R7715 T9389 T9391 nsubj NF-κB,inhibit
R7751 T9451 T9453 nmod [,]
R7752 T9452 T9453 nummod 26,]
R7754 T9453 T9450 dobj ],pathway
R7755 T9454 T9427 punct .,indicate

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T8684 1307-1316 Regulation denotes regulated
T8683 1307-1316 Regulation denotes regulated
T8682 1367-1372 Protein denotes MAPKs
T8681 1333-1365 Protein denotes mitogen-activated protein kinase
T8680 1288-1292 Protein denotes Nrf2
T8679 1278-1283 Protein denotes NF-κB
T8678 1125-1136 Binding denotes interaction
T8677 1177-1184 Protein denotes histone
T8676 1164-1167 Protein denotes CBP
T8675 1146-1160 Protein denotes CH1-KIX domain
T8674 1073-1076 Protein denotes ARE
T8673 1068-1072 Protein denotes Nrf2
T8672 1036-1053 Protein denotes NF-κB p65 subunit
T8671 997-1004 Negative_regulation denotes inhibit
T8670 1005-1009 Protein denotes Nrf2
T8669 987-992 Protein denotes NF-κB
T8668 804-814 Positive_regulation denotes activation
T8667 795-803 Positive_regulation denotes Enhanced
T8666 905-914 Negative_regulation denotes deficient
T8665 804-814 Positive_regulation denotes activation
T8664 900-904 Protein denotes Nrf2
T8663 818-823 Protein denotes NF-κB
T8662 565-572 Positive_regulation denotes induces
T8661 573-585 Positive_regulation denotes augmentation
T8660 547-556 Negative_regulation denotes depletion
T8659 589-594 Protein denotes NF-κB
T8658 560-564 Protein denotes Nrf2
T8657 470-473 Protein denotes SFN
T8656 445-449 Protein denotes Nrf2
T8655 361-366 Protein denotes NF-κB
T8654 233-240 Negative_regulation denotes inhibit
T8653 233-240 Negative_regulation denotes inhibit
T8652 233-240 Negative_regulation denotes inhibit
T8651 233-240 Negative_regulation denotes inhibit
T8650 233-240 Negative_regulation denotes inhibit
T8649 295-308 Localization denotes translocation
T8648 295-308 Localization denotes translocation
T8647 295-308 Localization denotes translocation
T8646 287-294 Entity denotes nuclear
T8645 249-264 Phosphorylation denotes phosphorylation
T8644 249-264 Phosphorylation denotes phosphorylation
T8643 335-340 Protein denotes NF-κB
T8642 276-278 Protein denotes κB
T8641 269-275 Protein denotes p65 NF
T8640 245-248 Protein denotes IκB
T8639 241-244 Protein denotes IKK
T8638 206-209 Protein denotes SFN
T8637 171-176 Protein denotes NF-κB
T8636 85-89 Protein denotes Nrf2
R7003 T8639 T8644 themeOf IKK,phosphorylation
R7021 T8664 T8666 themeOf Nrf2,deficient
R7022 T8665 T8667 themeOf activation,Enhanced
R7023 T8667 T8668 themeOf Enhanced,activation
R7024 T8670 T8671 themeOf Nrf2,inhibit
R7025 T8671 T8669 Cause inhibit,NF-κB
R7026 T8676 T8678 themeOf CBP,interaction
R7027 T8679 T8683 themeOf NF-κB,regulated
R7028 T8680 T8684 themeOf Nrf2,regulated
R7004 T8639 T8647 themeOf IKK,translocation
R7005 T8640 T8645 themeOf IκB,phosphorylation
R7006 T8641 T8648 themeOf p65 NF,translocation
R7007 T8642 T8649 themeOf κB,translocation
R7008 T8644 T8650 themeOf phosphorylation,inhibit
R7009 T8645 T8651 themeOf phosphorylation,inhibit
R7010 T8647 T8646 ToLoc translocation,nuclear
R7011 T8647 T8652 themeOf translocation,inhibit
R7012 T8648 T8646 ToLoc translocation,nuclear
R7013 T8648 T8653 themeOf translocation,inhibit
R7014 T8649 T8646 ToLoc translocation,nuclear
R7015 T8649 T8654 themeOf translocation,inhibit
R7016 T8658 T8660 themeOf Nrf2,depletion
R7017 T8659 T8661 themeOf NF-κB,augmentation
R7018 T8661 T8662 themeOf augmentation,induces
R7019 T8662 T8660 Cause induces,depletion
R7020 T8663 T8665 themeOf NF-κB,activation

testone

Id Subject Object Predicate Lexical cue
T7099 1307-1316 Regulation denotes regulated
T7098 1154-1160 Entity denotes domain
T7097 1125-1136 Binding denotes interaction
T7096 1054-1063 Negative_regulation denotes repressed
T7095 997-1004 Negative_regulation denotes inhibit
T7094 905-914 Negative_regulation denotes deficient
T7093 547-556 Negative_regulation denotes depletion
T7092 423-433 Negative_regulation denotes attenuated
T7091 295-308 Localization denotes translocation
T7090 287-294 Entity denotes nuclear
T7089 249-264 Phosphorylation denotes phosphorylation
T7088 233-240 Negative_regulation denotes inhibit
T7070 1042-1045 Protein denotes p65
T7069 269-272 Protein denotes p65
R5817 T7069 T7091 themeOf p65,translocation
R5818 T7070 T7097 themeOf p65,interaction
R5828 T7089 T7088 themeOf phosphorylation,inhibit
R5829 T7090 T7091 locationOf nuclear,translocation
R5830 T7091 T7088 themeOf translocation,inhibit
R5831 T7097 T7096 causeOf interaction,repressed

test3

Id Subject Object Predicate Lexical cue
T7176 1307-1316 Regulation denotes regulated
T7175 1146-1153 Entity denotes CH1-KIX
T7174 1125-1136 Binding denotes interaction
T7173 1042-1045 Protein denotes p65
T7172 997-1004 Negative_regulation denotes inhibit
T7171 905-914 Negative_regulation denotes deficient
T7170 295-308 Localization denotes translocation
T7169 287-294 Entity denotes nuclear
T7168 269-272 Protein denotes p65
T7167 249-264 Phosphorylation denotes phosphorylation
T7166 233-240 Negative_regulation denotes inhibit
T7165 75-81 Regulation denotes effect
T7126 1042-1045 Protein denotes p65
T7125 269-272 Protein denotes p65
R5852 T7167 T7166 themeOf phosphorylation,inhibit
R5853 T7168 T7170 themeOf p65,translocation
R5854 T7169 T7170 locationOf nuclear,translocation
R5855 T7170 T7166 themeOf translocation,inhibit
R5856 T7173 T7174 themeOf p65,interaction
R5857 T7175 T7174 themeOf CH1-KIX,interaction